公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
公司地址 175 Derby Street, Bld 27, Hingham, MA, USA, 02043
電話號碼 +1 781 875-3605
傳真號碼 +1 781 556-5347
公司網頁 https://www.microbotmedical.com
員工數量 21
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Harel Gadot Chairman of the Board, President and Chief Executive Officer 美元 520.25K 29/04/2025
Dr. Juan Diaz-Cartelle Chief Medical Officer 美元 350.00K 29/04/2025
Mr. Simon Sharon Chief Technology Officer and General Manager, Microbot Israel 美元 241.46K 29/04/2025
Ms. Rachel Vaknin Chief Financial Officer and Principal Accounting Officer 美元 162.79K 29/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Scott R. Burell Independent Director 29/04/2025
Mr. Tal Wenderow Independent Director 29/04/2025
Mr. Harel Gadot Chairman of the Board, President and Chief Executive Officer 29/04/2025
Mr. Martin J. Madden Independent Director 29/04/2025
Mr. Prattipati Laxminarain Independent Director 29/04/2025
Ms. Aileen Stockburger Independent Director 29/04/2025
Mr. David J. Wilson Independent Director 29/04/2025
 
所屬ETF (更新日期: 07/03/2026 02:15)
代號 名稱 佔比% 持有日期
QQQSInvesco NASDAQ Future Gen 200 ETF0.04%27/02/2026
AVSCAvantis US Small Cap Equity ETF0.02%28/02/2026
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.